New Wound Test Could Cut Diabetes Amputation Rate.

Woundchek, a diagnostic test developed by UK-based Systagenix, could lower amputation rates among people with diabetes by detecting hard-to-treat wounds at an earlier stage. Woundchek tests the wound for "elevated protease activity," which is associated with chronic non-healing wounds.

By detecting elevated protease activity in wounds, the Woundchek test could allow healthcare professionals to begin treating wounds more aggressively at an earlier stage. Such intervention could reduce the number of wounds that progress to the point that amputation becomes necessary.

http://www.diabeteshealth.com/read/2012/03/07/7462/new-wound-test-could-cut-diabetes-amputation-rate/